Pieris achieves milestone payment in Sanofi collaboration

12-Feb-2014 - Germany

Pieris AG has achieved a preclinical milestone within its R&D collaboration with Sanofi, triggering an undisclosed payment, the company announced. The milestone relates to the generation of sub-nanomolar Anticalins® against multiple targets within a single therapeutic program, forming the building blocks for a multispecific program.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...